Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

		Keywords:		Sorafenib

		Phase:		Phase 1

		Treatment ID#s:		VT1668 NCT00093613

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: ? Recurrent: ? Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		05/01/2007

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Glioblastoma Multiforme Gliosarcoma Oligodendroglioma High Grade


		Comments:

		Treatment Type:		Chemotherapy.

		Contact:		Henry Ford Hospital Tom MikKelsen, MD, FRCP(C) Co-Director Contact: Dr. Tom Mikelsen Hermelin Brain Tumor Center E&R3096 Henry Ford Hospital 2799 West Grand Blvd Detroit, MI 48202- Phone:313 916-8641 Fax: 313 916-9855 Click here to send an email Website: www.nabtt.org/henry.html

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By